25
Nov

Promethera Biosciences has put together €25.3 million ($31.4 million) in equity and loans to hit the gas on its stem cell treatment for rare liver diseases.

…read more

Source: Belgium’s Promethera banks $31M for orphan disease R&D

    

0 No comments